Efficacy and safety of abatacept for patients with Sjögren's syndrome associated with rheumatoid arthritis: Rheumatoid Arthritis with Orencia Trial toward Sjögren's syndrome Endocrinopathy (ROSE) trial—an open-label, one-year, prospective study—Interim analysis of 32 patients for 24 weeks

Hiroto TsuboiDepartment of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki Prefecture, Japan

Isao MatsumotoDepartment of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki Prefecture, Japan

Shinya HagiwaraDepartment of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki Prefecture, Japan

Tomoya HirotaDepartment of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki Prefecture, Japan

Hiroyuki TakahashiDepartment of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki Prefecture, Japan

Hiroshi EbeDepartment of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki Prefecture, Japan

Masahiro YokosawaDepartment of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki Prefecture, Japan

Chihiro HagiyaDepartment of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki Prefecture, Japan

Hiromitsu AsashimaDepartment of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki Prefecture, Japan

Chinatsu TakaiDepartment of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki Prefecture, Japan

Haruka MikiDepartment of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki Prefecture, Japan

Naoto UmedaDepartment of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki Prefecture, Japan

Yuya KondoDepartment of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki Prefecture, Japan

Hiroshi OgishimaDepartment of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki Prefecture, Japan

Takeshi SuzukiDepartment of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki Prefecture, Japan

Shintaro HirataThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu City, Fukuoka Prefecture, Japan

Kazuyoshi SaitoThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu City, Fukuoka Prefecture, Japan

Yoshiya TanakaThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu City, Fukuoka Prefecture, Japan

Yoshiro HoraiUnit of Translational Medicine, Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

Hideki NakamuraUnit of Translational Medicine, Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

Atsushi KawakamiUnit of Translational Medicine, Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

Takayuki SumidaDepartment of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki Prefecture, JapanCorrespondence[email protected]

show all

Efficacy and safety of abatacept for patients with Sjögren's syndrome associated with rheumatoid arthritis: Rheumatoid Arthritis with Orencia Trial toward Sjögren's syndrome Endocrinopathy (ROSE) trial—an open-label, one-year, prospective study—Interim analysis of 32 patients for 24 weeks

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Efficacy and safety of abatacept for patients with Sjögren's syndrome associated with rheumatoid arthritis: Rheumatoid Arthritis with Orencia Trial toward Sjögren's syndrome Endocrinopathy (ROSE) trial—an open-label, one-year, prospective study—Interim analysis of 32 patients for 24 weeks

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date